Showing codes J0641 (Injection, levoleucovorin, not otherwise specified, 0.5 mg) — J0717 (Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered))

J0641 - Inj levoleucovorin nos 0.5mg
Long description: Injection, levoleucovorin, not otherwise specified, 0.5 mg
Code added date: 20090101.
Code effective date: 20230101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J0642 - Injection, khapzory, 0.5 mg
Long description: Injection, levoleucovorin (khapzory), 0.5 mg
Code added date: 20191001.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J0650 - Inj, levothyroxine nos 10mcg
Long description: Injection, levothyroxine sodium, not otherwise specified, 10 mcg
Code added date: 20240401.
Code effective date: 20240401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J0651 - Inj, levothyroxine, freskabi
Long description: Injection, levothyroxine sodium (fresenius kabi), not therapeutically equivalent to j0650, 10 mcg
Code added date: 20240401.
Code effective date: 20240701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J0652 - Inj, levothyroxine, hikma
Long description: Injection, levothyroxine sodium (hikma), not therapeutically equivalent to j0650, 10 mcg
Code added date: 20240401.
Code effective date: 20240701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J0665 - Inj, bupivacaine, nos, 0.5mg
Long description: Injection, bupivicaine, not otherwise specified, 0.5 mg
Code added date: 20230701.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J0670 - Inj mepivacaine hcl/10 ml
Long description: Injection, mepivacaine hydrochloride, per 10 ml
Code added date: 19860101.
Code effective date: 19970101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J0687 - Inj cefazolin (wg crit care)
Long description: Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg
Code added date: 20240701.
Code effective date: 20240701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J0688 - Inj cefazolin sodium, hikma
Long description: Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg
Code added date: 20240101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J0689 - Inj cefazolin sodium, baxter
Long description: Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg
Code added date: 20230101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J0690 - Cefazolin sodium injection
Long description: Injection, cefazolin sodium, 500 mg
Code added date: 19820101.
Code effective date: 20000101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J0691 - Inj lefamulin 1 mg
Long description: Injection, lefamulin, 1 mg
Code added date: 20200701.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J0692 - Cefepime hcl for injection
Long description: Injection, cefepime hydrochloride, 500 mg
Code added date: 20020101.
Code effective date: 20020101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J0693 - Inj., cefiderocol, 5 mg
Long description: Injection, cefiderocol, 5 mg
Code added date: 20210101.
Code effective date: 20211001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J0694 - Cefoxitin sodium injection
Long description: Injection, cefoxitin sodium, 1 gm
Code added date: 19920101.
Code effective date: 19970101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J0695 - Inj ceftolozane tazobactam
Long description: Injection, ceftolozane 50 mg and tazobactam 25 mg
Code added date: 20160101.
Code effective date: 20160101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J0696 - Ceftriaxone sodium injection
Long description: Injection, ceftriaxone sodium, per 250 mg
Code added date: 19900101.
Code effective date: 19970101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J0697 - Sterile cefuroxime injection
Long description: Injection, sterile cefuroxime sodium, per 750 mg
Code added date: 19900101.
Code effective date: 19970101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J0698 - Cefotaxime sodium injection
Long description: Injection, cefotaxime sodium, per gm
Code added date: 19910101.
Code effective date: 19970101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J0699 - Inj, cefiderocol, 10 mg
Long description: Injection, cefiderocol, 10 mg
Code added date: 20211001.
Code effective date: 20211001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J0701 - Inj. cefepime hcl (baxter)
Long description: Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg
Code added date: 20230101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J0702 - Betamethasone acet&sod phosp
Long description: Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg
Code added date: 19950101.
Code effective date: 20080101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J0703 - Inj, cefepime hcl (b braun)
Long description: Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg
Code added date: 20230101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J0706 - Caffeine citrate injection
Long description: Injection, caffeine citrate, 5 mg
Code added date: 20020101.
Code effective date: 20020101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J0710 - Cephapirin sodium injection
Long description: Injection, cephapirin sodium, up to 1 gm
Code added date: 19820101.
Code effective date: 19970101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J0712 - Ceftaroline fosamil inj
Long description: Injection, ceftaroline fosamil, 10 mg
Code added date: 20120101.
Code effective date: 20160101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J0713 - Inj ceftazidime per 500 mg
Long description: Injection, ceftazidime, per 500 mg
Code added date: 19960101.
Code effective date: 19970101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J0714 - Ceftazidime and avibactam
Long description: Injection, ceftazidime and avibactam, 0.5 g/0.125 g
Code added date: 20160101.
Code effective date: 20160101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J0715 - Ceftizoxime sodium / 500 mg
Long description: Injection, ceftizoxime sodium, per 500 mg
Code added date: 19950101.
Code effective date: 19970101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J0716 - Centruroides immune f(ab)
Long description: Injection, centruroides immune f(ab)2, up to 120 milligrams
Code added date: 20130101.
Code effective date: 20130101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J0717 - Certolizumab pegol inj 1mg
Long description: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
Code added date: 20140101.
Code effective date: 20140101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF